Focus: JPM is a small-molecule and diagnostic manufacturing company based in Jordan specializing in the diagnostics segment. Limited public data constrains assessment of market position and operational scale.
Profile data last refreshed 4h ago · AI intelligence enriched 2mo ago
Open Jobs
2+2 this month
Stable — net +2 jobs in 30d
2 added, 0 removed. Backfill posture.
Should You Work at JPM?
AI assessmentJPM represents a niche manufacturing play with established generics portfolio, but minimal hiring and data opacity make it high-risk for career growth seekers.
Why Work Here
- Pipeline includes three Phase 4 commercialized ADHD programs (Foquest, Guanfacine ER, Lisdexamfetamine) with established market presence
- Exposure to vaccine development through MVA-BN-WEV programs spanning Phase 1-2 in rare indications (equine and viral encephalitis)
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
5 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Stable
Peak
Phase 4 market-stage ADHD therapeutic with active trial ongoing, representing established revenue contributor.
Guanfacine extended-release
Help build intelligence for JPM
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.